SCHEMBL22730185

SCHEMBL22730185

CCC(C)(C)C[SiH](Br)C(C)(C)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
TAAR1 Q96RJ0 1/20 0.35
KCNN4 O15554 1/20 0.34
MAPK1 P28482 1/20 0.33
ALDH1A1 P00352 3/20 0.31
ALOX15 P16050 1/20 0.31
RIPK1 Q13546 1/20 0.31
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
CYP3A4 P08684 1/20 0.31
NR3C2 P08235 1/20 0.30
MEN1 O00255 1/20 0.30
GAA P10253 1/20 0.30
PKM P14618 1/20 0.30
TSHR P16473 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22730245 0.85 CYP2C19 (0.36) CYP2C19HIF1ATAAR1KCNN4MAPK1
SCHEMBL22730220 0.82 CYP2C19 (0.39) CYP2C19HIF1ATAAR1KCNN4MAPK1
SCHEMBL22730228 0.82 TAAR1 (0.41) CYP2C19HIF1ATAAR1MAPK1ALDH1A1
SCHEMBL22730244 0.82 CYP2C19 (0.34) CYP2C19HIF1ATAAR1KCNN4MAPK1
SCHEMBL22734822 0.80 CYP2C19 (0.41) CYP2C19HIF1ATAAR1KCNN4MAPK1
SCHEMBL22730213 0.78 CYP2C19 (0.36) CYP2C19HIF1ATAAR1KCNN4MAPK1
SCHEMBL22730248 0.78 CYP2C19 (0.36) CYP2C19HIF1ATAAR1KCNN4MAPK1
SCHEMBL22730204 0.72 CYP2C19 (0.37) CYP2C19HIF1ATAAR1KCNN4MAPK1
SCHEMBL16538512 0.67 TAAR1 (0.43) CYP2C19HIF1ATAAR1KCNN4MAPK1
SCHEMBL22730164 0.67 CYP2C19 (0.39) CYP2C19HIF1ATAAR1KCNN4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066427-B2 Organosilane compounds having bulky substituent and preparation thereof SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-07-20 US disclosed
US-20200385411-A1 ORGANOSILANE COMPOUNDS HAVING BULKY SUBSTITUENT AND PREPARATION THEREOF SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-12-10 US disclosed
EP-3747889-A1 ORGANOSILANE COMPOUNDS HAVING BULKY SUBSTITUENT AND PREPARATION THEREOF Shin-Etsu Chemical Co., Ltd. (JP) 2020-12-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11066427-B2 Organosilane compounds having bulky substituent and preparation thereof C1S, C1R, C9 CYP2C19 170/4885HIF1A 3133/4885TAAR1 1233/4885
US-20200385411-A1 ORGANOSILANE COMPOUNDS HAVING BULKY SUBSTITUENT AND PREPARATION THEREOF C1S, C1R, C9 CYP2C19 170/4885HIF1A 3133/4885TAAR1 1233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.